What Investors Need to Know This Week in Markets

By |

Watch

Midas Letter

The Digital Businesss Channel for Cannabis, Crypto and Technology Stocks.

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.

The stock market had a mixed week last week. We saw a “mini-rotation” out of growth stocks, technology, and stay-at-home stocks into back-to-normal stocks. There is a resurgence in commodities and undervalued sectors like shippers, hotels, airlines, and cruise liners.

This is happening mainly because of the decline in hospital cases while vaccine numbers rise. This on top of the $1.9 trillion Biden stimulus bill and Yellen’s trillion-dollar in the treasury bank account where the extra capital will eventually make its way back into the stock market.

Although, there is a fear of inflation. As short-term rates remain steady and long-term rates increase – a simple sign that inflation is ahead of us.

This week we have a slew of quarterly earnings with a heavy focus on retail-facing companies.

Watch the entire Monday morning roundtable to see our recommendations in trading strategies for this week.

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.